J Biol Chem, Vol. 274, Issue 40, 28169-28174, October 1, 1999
Common Pathway for the Ubiquitination of I
B
, I
B
,
and I
B
Mediated by the F-Box Protein FWD1*
Michiko
Shirane
§,
Shigetsugu
Hatakeyama
§,
Kimihiko
Hattori
§,
Keiko
Nakayama§¶, and
Kei-ichi
Nakayama
§¶
From the
Department of Molecular and Cellular Biology
and ¶ Laboratory of Embryonic and Genetic Engineering, Medical
Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, and
§ CREST, Japan Science and Technology Corporation,
Kawaguchi 332-0012, Japan
 |
ABSTRACT |
FWD1 (the mouse homolog of Drosophila
Slimb and Xenopus
TrCP, a member of the F-box- and WD40
repeat-containing family of proteins, and a component of the SCF
ubiquitin ligase complex) was recently shown to interact with I
B
and thereby to promote its ubiquitination and degradation. This protein
has now been shown also to bind to I
B
and I
B
as well as to
induce their ubiquitination and proteolysis. FWD1 was shown to
recognize the conserved DSG
XS motif (where
represents the hydrophobic residue) present in the
NH2-terminal regions of these three I
B proteins only
when the component serine residues are phosphorylated. However, in
contrast to I
B
and I
B
, the recognition site in I
B
for FWD1 is not restricted to the DSG
XS motif; FWD1 also
interacts with other sites in the NH2-terminal region of
I
B
. Substitution of the critical serine residues in the
NH2-terminal regions of I
B
, I
B
, and I
B
with alanines also markedly reduced the extent of FWD1-mediated
ubiquitination of these proteins and increased their stability. These
data indicate that the three I
B proteins, despite their substantial
structural and functional differences, all undergo ubiquitination
mediated by the SCFFWD1 complex. FWD1 may thus play an
important role in NF-
B signal transduction through regulation of the
stability of multiple I
B proteins.
 |
INTRODUCTION |
The transcription factor nuclear factor-
B
(NF-
B)1 plays a central
role in the activation of many genes that are important in inflammatory
and immune responses as well as in the response to cellular stress
(1-4). NF-
B consists of homo- and heterodimeric complexes of
members of the Rel family of proteins. To date, five Rel proteins have
been identified in mammals as follows: p50, p52, p65 (RelA), c-Rel, and
Rel-B, the first two of which are synthesized as p105 and p100
precursors, respectively (4-6). These proteins bind specifically to
B motifs located in the promoters and enhancers of target genes,
resulting in transcriptional activation. Furthermore, they all share an
~300-amino acid region of homology, known as the Rel homology domain,
that is responsible for DNA binding, dimerization, and interaction with
inhibitory proteins of the I
B family.
The I
B family of inhibitory proteins includes I
B
, I
B
,
I
B
, I
B
, and Bcl-3 in higher vertebrates (Fig.
1A), all of which contain
multiple regions of homology known as ankyrin-repeat motifs (4). Such
repeats mediate protein-protein interactions, and the specific
interaction between ankyrin repeats of I
B proteins and the Rel
homology domain of Rel proteins appears to be an important and
evolutionarily conserved feature of the regulation of NF-
B (7). The
number of ankyrin repeats varies among the different I
B proteins and
appears to influence the specificity with which I
B pairs with a Rel
dimer. The Rel precursor proteins p100 and p105 also contain ankyrin
repeats and are sometimes included in the I
B family.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 1.
Structural organization of members of the
I B family of proteins. A,
schematic representation of the structure of I B proteins. All
members of the I B family contain ankyrin repeats, the number varies
from five to seven among the different proteins. I B , I B ,
and Bcl-3 each contain a PEST sequence in the region COOH-terminal to
the ankyrin repeats, whereas I B contains a PEST-like sequence in
the NH2-terminal region. Serine residues present within
SXXXS and DSG XS motifs are indicated, as are the total
number of amino acids in each protein. B, alignment of amino
acid sequences required for association with FWD1 in I B ,
I B , I B , -catenin, and Vpu. Arrows indicate
serine residues subjected to phosphorylation by IKK for I B proteins,
by glycogen synthase kinase-3 for -catenin, and by casein kinase
II for Vpu. Residue numbers are indicated. C, alignment of
amino acid sequences of the SXXXS motifs in I B ; the
first and second sequences overlap.
|
|
I
B
, the best characterized member of the I
B family, is a
37-kDa protein with a tripartite structural organization that is also
apparent in I
B
and which consists of (i) an
NH2-terminal domain that is phosphorylated in response to
extracellular signals, (ii) a central ankyrin-repeat domain, and (iii)
a COOH-terminal PEST domain that is important in the basal turnover of
the protein (6, 8, 9). The defining functional characteristic of I
B
is its ability to confer rapid but transient induction of NF-
B activity as a result of its participation in an autoregulatory feedback loop. Activation of NF-
B leads to up-regulation of
transcription of the I
B
gene, and the consequent
increase in the amount of I
B
serves to shut off the activation
signal (10-15).
I
B
is a 45-kDa protein and, like I
B
, binds p50-p65 and
p50-c-Rel complexes (16, 17). Functionally, I
B
and I
B
differ with regard both to the nature of the incoming signal as well as
to the timing of the onset of and the duration of the response (18).
Both I
B
and I
B
are rapidly degraded after exposure of cells
to an appropriate stimulus; however, whereas transcription of the
I
B
gene is induced as a result of NF-
B activation
that of the I
B
gene is not (16). Thus, the abundance
of I
B
remains low until the NF-
B-activating signal is attenuated.
I
B
is degraded with slower kinetics than are I
B
and
I
B
(17, 19). Unlike I
B
and I
B
, I
B
contains a
cluster of serine residues at the NH2 terminus and lacks a
PEST domain at the COOH terminus (Fig. 1A), suggesting that
these differences in structure may underlie the differences in
function. The NH2-terminal region of I
B
is rich in
Pro, Glu, Asp, Ser, and Thr residues (61 out of 118 residues; 51.7%)
and resembles a PEST sequence (17). I
B
does not interact with
either p50 or p52; instead, it associates exclusively with p65-p65 and
p65-c-Rel complexes and therefore likely regulates the transcription of
genes, such as that for interleukin-8, whose promoters bind
preferentially to p65 and c-Rel complexes (19, 20).
The dimeric NF-
B complex is normally sequestered in an inactive form
in the cytoplasm through interaction with I
B. In response to signals
such as tumor necrosis factor, interleukin-1, lipopolysaccharide, ultraviolet irradiation, and viral infection, I
B proteins are rapidly phosphorylated by a protein kinase complex known as IKK (I
B
kinase) (21-29). The IKK complex contains at least four kinases (IKK
, IKK
, IKK
(or NEMO), and NIK) and a scaffold protein
(IKAP) (30). IKK phosphorylates the 2 serine residues of the
DSG
XS motif (where
represents the hydrophobic
residue) in the NH2-terminal regions of I
B
(Ser-32
and Ser-36), I
B
(Ser-19 and Ser-23), and I
B
(Ser-18 and
Ser-22) (Fig. 1B). Such phosphorylation of I
B
triggers
its rapid degradation by ubiquitin-mediated proteolysis, thereby
allowing translocation of NF-
B to the nucleus and activation of
target genes (31-33). However, it has remained unknown whether other
members of the I
B family are also ubiquitinated in response to cell
stimulation and, if so, whether the phosphorylation of the
DSG
XS motifs of I
B
and I
B
is also required
for their ubiquitin-dependent degradation.
The ubiquitin-proteasome pathway of protein degradation is an important
mechanism by which the abundance of specific cellular proteins is
regulated (34-36). The formation of ubiquitin-protein conjugates is
mediated by three enzymes that participate in a series of ubiquitin
transfer reactions: a ubiquitin-activating enzyme (E1), a
ubiquitin-conjugating enzyme (E2), and a ubiquitin ligase (E3). The
specificity of protein ubiquitination often derives from the E3
ubiquitin ligases. Proteins that are polyubiquitinated by these enzymes
are subjected to degradation by the 26 S proteasome (36). Recent
genetic and biochemical studies in yeast have identified a class of E3
ligases, termed SCF complexes, that are required for degradation of
cyclins and their inhibitors as well as for that of an increasing
number of other proteins (37-39). SCF complexes consist of the
invariable components Skp1 and Cdc53 (Cullin or Cul1) as well as a
variable component known as an F-box protein, which binds to Skp1
through the F-box motif. F-box proteins serve as receptors for the
target protein, which is usually phosphorylated.
We and others (40-48) recently showed that FWD1, the mouse homolog of
Drosophila Slimb and Xenopus
TrCP and a member
of the F-box and WD40 repeat family of proteins, is specifically
associated with I
B
and
-catenin only when the latter is
phosphorylated at the serine residues in the DSG
XS motif.
FWD1 also interacts with the Skp1-Cul1 complex through its F-box
domain, thereby forming an SCF complex, SCFFWD1. Thus, the
phosphorylation of I
B
results in the recruitment of FWD1, which
links I
B
to the ubiquitination machinery. SCFFWD1
therefore plays an important role in transcriptional regulation by
NF-
B as a result of its control of I
B
protein stability.
We have now investigated whether FWD1 contributes to ubiquitin-mediated
proteolysis of I
B family members other than I
B
. Our data show
that I
B
and I
B
are also ubiquitinated and that FWD1
mediates the ubiquitination of these proteins in response to their
phosphorylation by the IKK complex, thereby triggering their degradation.
 |
EXPERIMENTAL PROCEDURES |
Cell Culture--
293T cells were grown at 37 °C and under an
atmosphere of 5% CO2 in Dulbecco's modified Eagle's
medium (Life Technologies, Inc.) supplemented with 10% (v/v) fetal
bovine serum (Life Technologies, Inc.).
Construction of Expression Plasmids and
Mutagenesis--
Molecular cloning of the FWD1 and FWD2 cDNAs was
described previously (40, 41). Complementary DNAs encoding FWD1, FWD2, and FWD1(
F), each protein tagged at the NH2 terminus
with the FLAG or Myc epitope, were generated with the use of the
polymerase chain reaction, as performed with the high fidelity
thermostable DNA polymerase KOD (Toyobo, Tokyo, Japan); they were then
sequenced and subcloned into pcDNA3 (Invitrogen, Carlsbad, CA).
FWD1(
F) contains residues 1-140 of FWD1 fused to residues 194-569.
I
B
, I
B
, I
B
, and IKK
cDNAs were kindly provided
by H. Nakano (27). The I
B cDNAs were subcloned into pcDNA3
with the FLAG or Myc epitope tag, and the cDNA encoding
FLAG- or Myc-tagged IKK
was cloned with the TA Cloning
System (Invitrogen).
Transfection, Immunoprecipitation, and Immunoblot
Analysis--
293T cells were transfected by the calcium phosphate
method or with the use of the LipofectAMINE reagent (Life Technologies, Inc.). After 48 h, the cells were lysed with a solution containing 50 mM Tris-HCl (pH 7.6), 300 mM NaCl, 0.5%
Triton X-100 (v/v), aprotinin (10 µg/ml), leupeptin (10 µg/ml), 10 mM iodoacetamide, 1 mM phenylmethylsulfonyl
fluoride, 0.4 mM Na3VO4, 0.4 mM EDTA, 10 mM NaF, and 10 mM
sodium pyrophosphate. The cell lysates were pretreated with 50 µl of
protein G-Sepharose beads (Amersham Pharmacia Biotech) for 1 h at
4 °C and were then incubated with 5 µg of the appropriate
antibodies and protein G-Sepharose beads for 4 h at 4 °C. The
resulting immunoprecipitates were then washed thoroughly four times
with ice-cold lysis buffer, fractionated by SDS-polyacrylamide gel
electrophoresis (PAGE), and subjected to immunoblot analysis with
antibodies (1 µg/ml) to Myc (9E10; Roche Diagnostics, Tokyo, Japan),
to the FLAG epitope (M5; Sigma), or to ubiquitin (1B3; MBL, Nagoya, Japan).
Pulse-Chase Experiments--
Transfected 293T cells were
metabolically labeled with Tran35S-label (ICN, Costa Mesa,
CA) at a concentration of 100 µCi/ml for 1 h. After incubation
for various times in the absence of isotope, the cells were lysed and
subjected to immunoprecipitation with antibodies to Myc (9E10) and
protein G-Sepharose. The immunoprecipitates were fractionated by
SDS-PAGE and subjected to quantitative analysis with a BAS-2000 image
analyzer (Fuji Film, Kanagawa, Japan).
 |
RESULTS |
FWD1-induced Ubiquitination of I
B
, I
B
, and
I
B
--
We and others (40, 42-44, 46, 47) have recently shown
that the FWD1 component of the ubiquitin ligase complex
SCFFWD1 serves as an intracellular receptor for I
B
that has been phosphorylated at the DSG
XS motif by IKK.
We therefore investigated whether FWD1 also associates with I
B
and I
B
through their phosphorylated DSG
XS motifs.
Expression plasmids encoding FLAG-tagged I
B
, I
B
, I
B
,
or their SA mutants, in which serine was replaced with alanine at
positions 32 and 36 (S32A/S36A), 19 and 23 (S19A/S23A), or 18 and 22 (S18A/S22A), respectively, were introduced into 293T cells with or
without plasmids encoding Myc-tagged IKK
, AU1-tagged MEKK1, and
Myc-tagged FWD1. Immunoprecipitation assays revealed that Myc-tagged
FWD1 was present in the I
B
, I
B
, and I
B
immunoprecipitates prepared with antibodies to FLAG (Fig.
2). The SA mutants of I
B
and
I
B
did not interact with FWD1, indicating that FWD1 recognizes the serine-phosphorylated DSG
XS motif. In contrast,
association of the SA mutant of I
B
with FWD1 was apparent. The
observed pattern of ubiquitination of the I
B proteins was consistent
with the pattern of FWD1 binding. FWD1 markedly increased the
ubiquitination of wild-type I
B
and I
B
but not that of the
corresponding SA mutants. In contrast, both wild-type I
B
and its
SA mutant were ubiquitinated in the presence of FWD1, although the
extent of ubiquitination of the SA mutant was less than that apparent
with the wild-type protein. These results indicate that FWD1 interacts with all three I
B proteins and thereby promotes their
ubiquitination, although the mode of binding appears to differ between
I
B
and I
B
on the one hand and I
B
on the other,
probably as a result of the corresponding structural differences
between these proteins: I
B
contains additional serine residues
present within SXXXS motifs in the NH2-terminal
region and lacks a COOH-terminal PEST domain (Fig. 1).

View larger version (53K):
[in this window]
[in a new window]
|
Fig. 2.
FWD1-induced ubiquitination of phosphorylated
I B ,
I B , and
I B . 293T cells
were transfected with expression plasmids encoding FLAG-tagged
wild-type (wt) I B proteins or the corresponding SA
mutants either alone or together with plasmids encoding Myc-IKK ,
AU1-MEKK1, and Myc-FWD1 as indicated. Cell lysates were prepared and
subjected to immunoprecipitation (IP) with antibodies to the
FLAG epitope, and the resulting immunoprecipitates were subjected to
immunoblot (IB) analysis with antibodies to FLAG, to Myc, or
to ubiquitin (Ub), as indicated. Polyubiquitinated I B
proteins are indicated by I B-Ubn. A portion of
the cell lysates corresponding to 10% of the input for
immunoprecipitation was also subjected to immunoblot analysis with
antibodies to Myc in order to indicate the levels of expression of
IKK and FWD1.
|
|
Phosphorylation-induced Ubiquitination of I
B
Mediated by
FWD1--
To investigate further the role of FWD1 in I
B
ubiquitination, we examined whether IKK activity is required for this
reaction. Expression of IKK
alone with I
B
in 293T cells
resulted in a small increase in the extent of I
B
ubiquitination
(Fig. 3), which was likely mediated by
endogenous FWD1. However, expression of both IKK
and FWD1 together
with I
B
induced a marked increase in I
B
ubiquitination. The
interaction of I
B
with FWD1 was observed only in the presence of
exogenous IKK
. Another mammalian F-box and WD40 repeat protein, FWD2
(or MD6), neither interacted with I
B
, even in the presence of
IKK
, nor increased the extent of its ubiquitination, confirming that
the interaction between FWD1 and I
B
is specific. Furthermore,
FWD1 did not bind to the S19A/S23A mutant of I
B
in the presence
of IKK
. These results suggest that FWD1-induced ubiquitination
requires prior phosphorylation of I
B
on Ser-19 and Ser-23 by the
IKK complex.

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 3.
Phosphorylation-induced ubiquitination of
I B mediated by
FWD1. 293T cells were transfected with expression plasmids
encoding Myc-tagged wild-type I B or its S19A/S23A mutant either
alone or together with plasmids encoding FLAG-FWD1, FLAG-FWD2, or
FLAG-IKK , as indicated. Cell lysates were subjected to
immunoprecipitation (IP) with antibodies to Myc, and the
resulting precipitates were subjected to immunoblot (IB)
analysis with antibodies to Myc, to FLAG, or to ubiquitin as indicated.
A portion of the cell lysates corresponding to 10% of the input for
immunoprecipitation was also subjected to immunoblot analysis with
antibodies to FLAG in order to indicate the levels of expression of
IKK , FWD1, and FWD2.
|
|
Requirement of the F-Box Domain in FWD1 for I
B
Ubiquitination--
We previously showed that FWD1 links I
B
to
the Skp1-Cul1 complex as a result of the interaction of Skp1 with the
F-box motif of FWD1. We therefore examined whether the F-box domain of
FWD1 is also essential for the ubiquitination of I
B
. The
FWD1(
F) mutant, which lacks the F-box domain (amino acids 148 to
192), did not induce ubiquitination of I
B
in the presence of
IKK
, although FWD1(
F) did interact with I
B
(Fig.
4A). A pulse-chase experiment
indicated that expression of FWD1 increased the rate of degradation of
I
B
relative to that apparent in cells expressing FWD2 (Fig.
4B). The FWD1(
F) mutant had no such effect, consistent with its inability to induce ubiquitination of I
B
. Together, these observations suggest that FWD1, acting as a component of the
SCFFWD1 complex, functions as an intracellular receptor for
I
B
and thereby promotes the ubiquitination and degradation of
this protein.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 4.
Requirement of the F box motif of FWD1 for
ubiquitination and degradation of
I B .
A, 293T cells were transfected with expression plasmids
encoding Myc-I B and FLAG-IKK alone or together with plasmids
encoding FLAG-tagged wild-type (wt) FWD1 or FWD1( F), as
indicated. Cell lysates were subjected to immunoprecipitation
(IP) with antibodies to Myc, and the resulting precipitates
were subjected to immunoblot (IB) analysis with antibodies
to Myc, to FLAG, or to ubiquitin. A portion of the cell lysates
corresponding to 10% of the input for immunoprecipitation was also
subjected to immunoblot analysis with antibodies to FLAG in order to
indicate the levels of expression of IKK , FWD1, and FWD1( F).
B, 293T cells were transfected with expression plasmids
encoding Myc-tagged I B , FLAG-tagged IKK , and either
FLAG-tagged FWD2 (top), FWD1 (middle), or
FWD1( F) (bottom). After pulse labeling with
[35S]methionine and [35S]cysteine, the
cells were incubated for the indicated chase periods in the absence of
isotope and then lysed. Cell lysates were subjected to
immunoprecipitation with antibodies to Myc, and the resulting I B
precipitates were subjected to SDS-PAGE and autoradiography.
|
|
FWD1-induced Ubiquitination of I
B
--
We have shown that
FWD1 promotes the ubiquitination of I
B
(Fig. 2). However, unlike
I
B
and I
B
, the recognition motif for FWD1 in I
B
was
not restricted to the phosphorylated DSG
XS sequence
because the S18A/S22A mutant of I
B
was also ubiquitinated, although to a reduced extent compared with that apparent with the
wild-type protein. We therefore investigated whether phosphoserine residues located within other SXXXS motifs in the
NH2-terminal region of I
B
contribute to FWD1-mediated
ubiquitination of this protein. FWD1 bound to I
B
and elicited
marked ubiquitination in the absence of exogenous IKK
(Fig.
5A), whereas the
ubiquitination of I
B
and I
B
requires exogenous IKK
activity. Furthermore, an I
B
mutant (SA-all) in which all nine
serine residues within SXXXS motifs were replaced with
alanines also associated with FWD1 and was ubiquitinated, although to a
reduced extent relative to that observed with the wild-type protein
(Fig. 5A). An I
B
mutant (
N) that lacked the entire
NH2-terminal domain (residues 1-118) neither bound to FWD1
nor was ubiquitinated. Thus, the susceptibility to ubiquitination of
the various I
B
proteins examined decreases in the rank order
wild-type > S18A/S22A > SA-all >
N. These results
suggest that FWD1 interacts predominantly with Ser-18 and Ser-22 within
the DSG
XS motif of I
B
but is also able to bind to
other serine residues in the NH2-terminal region of the
protein.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 5.
FWD1-induced ubiquitination of
I B .
A, requirement of the NH2-terminal region of
I B for both the binding of I B to FWD1 and its
ubiquitination. 293T cells were transfected with expression plasmids
encoding FLAG-p27 (negative control) or FLAG-FWD1, in combination with
vectors encoding Myc-tagged wild-type (wt) I B ,
I B (SA-all), or I B ( N). Cell lysates were subjected to
immunoprecipitation (IP) with antibodies to Myc, and the
resulting precipitates were subjected to immunoblot (IB)
analysis with antibodies to Myc, to FLAG, or to ubiquitin as indicated.
A portion of the cell lysates corresponding to 10% of the input for
immunoprecipitation was also subjected to immunoblot analysis with
antibodies to FLAG in order to indicate the levels of expression of p27
and FWD1. B, effect of a kinase-negative IKK mutant
(K44M) on the binding of I B to FWD1 and its ubiquitination. 293T
cells were transfected with expression plasmids encoding Myc-I B
and FLAG-FWD1, in the absence or presence of a vector encoding
IKK (K44M) at increasing concentrations, as indicated. Cell lysates
were subjected to immunoprecipitation with antibodies to Myc, and the
resulting precipitates were subjected to immunoblot analysis with
antibodies to Myc, to FLAG, or to ubiquitin. A portion of the cell
lysates corresponding to 10% of the input for immunoprecipitation was
subjected to immunoblot analysis with antibodies to FLAG to indicate
the levels of expression of IKK (K44M) and FWD1.
|
|
With regard to the observation that FWD1-mediated ubiquitination of
I
B
did not require exogenous IKK, it was possible that FWD1
interacted with I
B
in an IKK-independent manner. Alternatively, the small amount of endogenous IKK might have been sufficient to
promote the FWD1-I
B
interaction. Immunoblot analysis indeed revealed the presence of endogenous IKK
in 293T cells (data not shown). We investigated these two possibilities by introducing a
kinase-negative mutant of IKK
(K44M) into 293T cells to inhibit the
endogenous IKK activity. This mutant markedly inhibited the interaction
between FWD1 and I
B
as well as FWD1-induced ubiquitination of
I
B
in a dose-dependent manner (Fig. 5B),
suggesting that endogenous IKK is required for both these events. Thus,
whereas signal-induced activation of the IKK complex is required for
the proteolysis of I
B
and I
B
, I
B
appears to be
constitutively degraded as a result of the low level of endogenous IKK activity.
FWD1-induced Degradation of I
B
, I
B
, and
I
B
--
To investigate further whether the
phosphorylation-induced interaction with FWD1 promotes the degradation
of I
B
, I
B
, and I
B
, we performed pulse-chase
experiments (Fig. 6). In the presence of
FWD1 and IKK
, both I
B
and I
B
were rapidly degraded,
although the kinetics of I
B
degradation were slightly slower that
those of I
B
degradation. The rates of degradation of the
I
B
(S32A/S36A) and I
B
(S19A/S23A) mutants were markedly
reduced relative to those of the corresponding wild-type proteins,
indicating that FWD1 promotes degradation of both I
B
and I
B
after specific phosphorylation of the DSG
XS motif. The
half-life of I
B
was longer than those of I
B
and I
B
,
as previously demonstrated (17). The I
B
(SA-all) mutant was more
stable than was wild-type I
B
, consistent with our observation
that the extent of ubiquitination of the mutant was markedly reduced
compared with that of the wild-type protein (Fig. 5A). Thus,
phosphorylation of serine residues present within SXXXS
motifs in its NH2-terminal region appears to influence the
stability of I
B
.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 6.
FWD1-induced degradation of phosphorylated
I B ,
I B , and
I B . 293T cells
transfected with vectors encoding the indicated Myc-tagged I B
proteins, FLAG-IKK , and FLAG-FWD1 were pulse-labeled with
[35S]methionine and [35S]cysteine, and then
incubated in the absence of isotope for the indicated chase periods.
Cell lysates were then subjected to immunoprecipitation with antibodies
to Myc, and the resulting precipitates were subjected to SDS-PAGE,
autoradiography, and scanning densitometry. The amount of each I B
protein is expressed as a percentage of that present at the beginning
of the chase period. , I B ; , I B (S32A/S36A); ,
I B ; , I B (S19A/ S23A); , I B ; ,
I B (SA-all).
|
|
 |
DISCUSSION |
We and others (40-48) previously showed that FWD1 mediates the
ubiquitination of I
B
and
-catenin by functioning as an
intracellular receptor that links these substrates to the core complex
of the SCF E3 ubiquitin ligase. Human FWD1 was also shown to interact with the Vpu protein of human immunodeficiency virus-type 1 (49). I
B
, I
B
, I
B
,
-catenin, and Vpu all share a
DSG
XS motif (Fig. 1B), the two serines in
which undergo signal-induced phosphorylation. This shared property
suggested that FWD1 might recognize the phosphorylated DSG
XS motif in each of these proteins, as we showed was
the case for I
B
. The phosphorylated DSG
XS motif
thus might constitute a signal for FWD1-mediated ubiquitination. In the
present study, we therefore investigated whether FWD1 also mediates the
ubiquitination of I
B
and I
B
. Indeed, our data show that
FWD1 also serves to link these two proteins to the core complex of the
SCF ubiquitin ligase in a phosphorylation-dependent manner.
The structural organization of I
B
differs from that of I
B
and I
B
(4). Whereas I
B
and I
B
contain a PEST domain in the COOH-terminal region, I
B
contains a putative PEST domain in the NH2-terminal region, upstream of the ankyrin repeats
(Fig. 1A) (17). The DSG
XS motif is present in
the NH2-terminal regions of all three proteins; however,
I
B
also contains four additional SXXXS motifs
clustered in this region (Fig. 1C). Although FWD1 interacts
with I
B
, I
B
, and I
B
, the mode of interaction with I
B
and I
B
appears to differ from that for I
B
. Thus,
mutation of the two serines in the DSG
XS motifs of
I
B
and I
B
to alanines prevented both the interaction of
these proteins with FWD1 and their FWD1-mediated ubiquitination as well
as increased their stability. These data indicate the absolute
requirement for the DSG
XS motif in the interaction of
I
B
or I
B
with FWD1. In contrast, mutation of the two
serines in the DSG
XS motif of I
B
did not prevent
its binding to FWD1. Furthermore, the I
B
(SA-all) mutant, in which
the serines in all five SXXXS motifs were replaced by
alanines, also interacted with FWD1, although the extent of its
ubiquitination was substantially reduced compared with that of the
wild-type protein. Hence, FWD1 appears to recognize motifs other than
SXXXS in I
B
. Together, our data indicate that FWD1 is
important for the ubiquitination of these three I
B proteins, although the manner of association appears to differ between I
B
and I
B
on the one hand and I
B
on the other hand.
Another difference between I
B
and I
B
versus
I
B
is that although FWD1 binding to and efficient ubiquitination
of I
B
and I
B
in 293T cells required introduction of both
FWD1 and IKK
, I
B
interacted with FWD1 and underwent
ubiquitination in the presence of exogenous FWD1 alone (without
introducing exogenous IKK
). Our observation that a kinase-negative
mutant of IKK
(K44M) inhibited both the interaction of I
B
with
FWD1 and its ubiquitination suggests that endogenous IKK activity was
necessary and sufficient for these reactions to proceed. However, we
also showed that IKK
phosphorylated I
B
specifically on Ser-18
and Ser-22 in transfected 293T cells (data not shown). This result
appears inconsistent with the observation that the I
B
(S18A/S22A)
mutant retained the ability to undergo ubiquitination, but it might be
explained by IKK
phosphorylation of other kinases or modulators that
promote the interaction of FWD1 with I
B
.
Although I
B
, I
B
, and I
B
all appear to undergo
FWD1-mediated ubiquitination, and at least I
B
and I
B
seem
to be phosphorylated in a similar manner, the three proteins exhibited
differential stabilities. It is possible that factors other than
phosphorylation of the DSG
XS motif affect the interaction
of FWD1 with the I
B proteins. Simeonidis et al. (7)
showed that the structural differences in the NH2-terminal
regions of I
B
, I
B
, and I
B
may contribute to the
differential stabilities of the three proteins. The COOH-terminal
structures, which are thought to control basal turnover, also differ
among the three proteins (6, 8, 9). Thus, regulatory mechanisms other
than the FWD1-dependent pathway also may contribute to
control of the stability of I
B proteins (50). Although the
underlying mechanisms responsible for the differential down-regulation
of I
B proteins remain to be fully characterized, it is clear that
FWD1 is an important regulator of NF-
B signaling.
 |
ACKNOWLEDGEMENTS |
We thank Drs. H. Nakano, K. Okumura, and S. Tanaka for the plasmids and cell lines used in this study; S. Matsushita, K. Shimoharada, N. Nishimura, R. Yasukochi and other
laboratory members for technical assistance; and M. Kimura for
secretarial assistance.
 |
FOOTNOTES |
*
This work was supported in part by a grant from the Ministry
of Education, Science, Sports and Culture of Japan.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept.
of Molecular and Cellular Biology, Medical Institute of Bioregulation,
Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka, Fukuoka
812-8582, Japan. Tel.: 81-92-642-6815; Fax.: 81-92-642-6819; E-mail:
nakayak1@bioreg.kyushu-u.ac.jp.
 |
ABBREVIATIONS |
The abbreviations used are:
NF-
B, nuclear
factor-
B;
IKK, I
B kinase;
PAGE, polyacrylamide gel
electrophoresis;
E3, ubiquitin ligase.
 |
REFERENCES |
| 1.
|
May, M. J.,
and Ghosh, S.
(1998)
Immunol. Today
19,
80-88[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Thanos, D.,
and Maniatis, T.
(1995)
Cell
80,
529-532[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Baldwin, A. S., Jr.
(1996)
Annu. Rev. Immunol.
14,
649-683[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Ghosh, S.,
May, M. J.,
and Kopp, E. B.
(1998)
Annu. Rev. Immunol.
16,
225-260[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Kopp, E. B.,
and Ghosh, S.
(1995)
Adv. Immunol.
58,
1-27[Medline]
[Order article via Infotrieve]
|
| 6.
|
Verma, I. M.,
Stevenson, J. K.,
Schwarz, E. M.,
Van Antwerp, D.,
and Miyamoto, S.
(1995)
Genes Dev.
9,
2723-2735[Free Full Text]
|
| 7.
|
Simeonidis, S.,
Stauber, D.,
Chen, G.,
Hendrickson, W. A.,
and Thanos, D.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
49-54[Abstract/Free Full Text]
|
| 8.
|
Davis, N.,
Ghosh, S.,
Simmons, D. L.,
Tempst, P.,
Liou, H. C.,
Baltimore, D.,
and Bose, H. R., Jr.
(1991)
Science
253,
1268-1271[Abstract/Free Full Text]
|
| 9.
|
Haskill, S.,
Beg, A. A.,
Tompkins, S. M.,
Morris, J. S.,
Yurochko, A. D.,
Sampson-Johannes, A.,
Mondal, K.,
Ralph, P.,
and Baldwin, A. S., Jr.
(1991)
Cell
65,
1281-1289[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Brown, K.,
Park, S.,
Kanno, T.,
Franzoso, G.,
and Siebenlist, U.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
2532-2536[Abstract/Free Full Text]
|
| 11.
|
Sun, S. C.,
Ganchi, P. A.,
Ballard, D. W.,
and Greene, W. C.
(1993)
Science
259,
1912-1915[Abstract/Free Full Text]
|
| 12.
|
Scott, M. L.,
Fujita, T.,
Liou, H. C.,
Nolan, G. P.,
and Baltimore, D.
(1993)
Genes Dev.
7,
1266-1276[Abstract/Free Full Text]
|
| 13.
|
de Martin, R.,
Vanhove, B.,
Cheng, Q.,
Hofer, E.,
Csizmadia, V.,
Winkler, H.,
and Bach, F. H.
(1993)
EMBO J.
12,
2773-2779[Medline]
[Order article via Infotrieve]
|
| 14.
|
Le Bail, O.,
Schmidt-Ullrich, R.,
and Israel, A.
(1993)
EMBO J.
12,
5043-5049[Medline]
[Order article via Infotrieve]
|
| 15.
|
Chiao, P. J.,
Miyamoto, S.,
and Verma, I. M.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
28-32[Abstract/Free Full Text]
|
| 16.
|
Thompson, J. E.,
Phillips, R. J.,
Erdjument-Bromage, H.,
Tempst, P.,
and Ghosh, S.
(1995)
Cell
80,
573-582[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Whiteside, S. T.,
Epinat, J. C.,
Rice, N. R.,
and Israel, A.
(1997)
EMBO J.
16,
1413-1426[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Kerr, L. D.,
Inoue, J.,
Davis, N.,
Link, E.,
Baeuerle, P. A.,
Bose, H. R., Jr.,
and Verma, I. M.
(1991)
Genes Dev.
5,
1464-1476[Abstract/Free Full Text]
|
| 19.
|
Simeonidis, S.,
Liang, S.,
Chen, G.,
and Thanos, D.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
14372-14377[Abstract/Free Full Text]
|
| 20.
|
Kunsch, C.,
and Rosen, C. A.
(1993)
Mol. Cell. Biol.
13,
6137-6146[Abstract/Free Full Text]
|
| 21.
|
Malinin, N. L.,
Boldin, M. P.,
Kovalenko, A. V.,
and Wallach, D.
(1997)
Nature
385,
540-544[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
DiDonato, J. A.,
Hayakawa, M.,
Rothwarf, D. M.,
Zandi, E.,
and Karin, M.
(1997)
Nature
388,
548-554[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Regnier, C. H.,
Song, H. Y.,
Gao, X.,
Goeddel, D. V.,
Cao, Z.,
and Rothe, M.
(1997)
Cell
90,
373-383[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Zandi, E.,
Rothwarf, D. M.,
Delhase, M.,
Hayakawa, M.,
and Karin, M.
(1997)
Cell
91,
243-252[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Mercurio, F.,
Zhu, H.,
Murray, B. W.,
Shevchenko, A.,
Bennett, B. L.,
Li, J.,
Young, D. B.,
Barbosa, M.,
Mann, M.,
Manning, A.,
and Rao, A.
(1997)
Science
278,
860-866[Abstract/Free Full Text]
|
| 26.
|
Woronicz, J. D.,
Gao, X.,
Cao, Z.,
Rothe, M.,
and Goeddel, D. V.
(1997)
Science
278,
866-869[Abstract/Free Full Text]
|
| 27.
|
Nakano, H.,
Shindo, M.,
Sakon, S.,
Nishinaka, S.,
Mihara, M.,
Yagita, H.,
and Okumura, K.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
3537-3542[Abstract/Free Full Text]
|
| 28.
|
Yamaoka, S.,
Courtois, G.,
Bessia, C.,
Whiteside, S. T.,
Weil, R.,
Agou, F.,
Kirk, H. E.,
Kay, R. J.,
and Israel, A.
(1998)
Cell
93,
1231-1240[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Rothwarf, D. M.,
Zandi, E.,
Natoli, G.,
and Karin, M.
(1998)
Nature
395,
297-300[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Cohen, L.,
Henzel, W. J.,
and Baeuerle, P. A.
(1998)
Nature
395,
292-296[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Palombella, V. J.,
Rando, O. J.,
Goldberg, A. L.,
and Maniatis, T.
(1994)
Cell
78,
773-785[CrossRef][Medline]
[Order article via Infotrieve]
|
|